Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy (Digestive Diseases and Sciences, (2020), 65, 1, (96-103), 10.1007/s10620-018-5433-5)

Zaid Bilgrami; Ameer Abutaleb; Kenechukwu Chudy-Onwugaje; Patricia Langenberg; Miguel Regueiro; David A. Schwartz; J. Kathleen Tracy; Leyla Ghazi; Seema A. Patil; Sandra M. Quezada; Katharine M. Russman; Charlene C. Quinn; Guruprasad Jambaulikar; Dawn B. Beaulieu; Sara Horst; Raymond K. Cross

ArticleOPEN ACCESS

Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy (Digestive Diseases and Sciences, (2020), 65, 1, (96-103), 10.1007/s10620-018-5433-5)

Digestive Diseases and Sciences

DOI: 10.1007/s10620-019-05953-4

3Citations

7Readers

Abstract

This manuscript is a secondary analysis of a large multicenter randomized controlled trial. The primary study is Cross RK et al., A Randomized Controlled Trial of TELEmedicine for patients with Inflammatory Bowel Disease (TELE-IBD). Am J Gastroenterol, 2019 Mar.

Cite

CITATION STYLE

APA

Bilgrami, Z., Abutaleb, A., Chudy-Onwugaje, K., Langenberg, P., Regueiro, M., Schwartz, D. A., … Cross, R. K. (2020, February 1). Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy (Digestive Diseases and Sciences, (2020), 65, 1, (96-103), 10.1007/s10620-018-5433-5). Digestive Diseases and Sciences. Springer. https://doi.org/10.1007/s10620-019-05953-4

Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy (Digestive Diseases and Sciences, (2020), 65, 1, (96-103), 10.1007/s10620-018-5433-5)

Abstract

Cite

Register to see more suggestions